Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma.

Curr Oncol · 2025 · PMC11854641 · PMID 39996918

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

We also showed a trend towards excellent response, with no deaths in patients with prior PD-1 blockade exposure who proceeded to alloSCT in CR (2-year OS rate of 100%), compared to three deaths among patients transplanted in PR (2-year OS rate of 61%).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.